用氧化驱动的纳米治疗药物用于癌症治疗
Zhiqiang Zhao1, Xinzhu Shan2, Hongyuan Zhang1
1Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
概括
氧化 (NO) 由于其抗瘤活性和生物安全性,在癌症治疗中表现有前途. 纳米药物输送系统 (Nano-DDS) 正在推进有效的NO输送到瘤,克服了以前的挑战.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 氧化 (NO) 具有显著的抗瘤特性和生物安全性,使其成为癌症治疗的有价值剂.
- 的气态性质对有效地传送到瘤部位提出了挑战.
- 纳米药物输送系统 (Nano-DDS) 为在体内有针对性的NO输送提供了一个有前途的解决方案.
研究的目的:
- 审查新兴的氧化驱动纳米疗法用于癌症治疗.
- 总结刺激内源性NO合成和提供NO捐赠者的进展.
- 讨论基于NO的组合疗法和未来的临床转化.
主要方法:
- 关于NO治疗,内源NO合成刺激和NO捐赠纳米治疗的最新文献的综述.
- 对NO的抗瘤机制和临床试验数据的分析.
- 对NO输送和多模式癌症治疗的纳米治疗策略的讨论.
主要成果:
- NO治疗显示出良好的生物安全性和高抗瘤活性,具有潜在的协同效应.
- 纳米-DDS在实现高效的 in vivo NO 输送方面取得了显著的成就.
- 新兴的策略包括刺激内源的NO生产和通过纳米载体的NO捐赠者的有针对性的输送.
结论:
- 基于NO的纳米疗法是一种快速发展的领域,在癌症治疗方面具有显著的潜力.
- 在临床转化方面仍然存在挑战,需要进一步研究针对性输送和组合疗法.
- 未来的方向侧重于优化NO输送系统,以提高效率和多式模式的癌症治疗.
相关概念视频
01:28Nitric Oxide Signaling Pathway
5.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:23Antihypertensive Drugs: Vasodilators
566
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
566
01:10Mechanism of Angiogenesis
5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K